AMPDB_3729 | Lycosin-I
PEPTIDE SUMMARY
Lycosin-I
1 General Description
AMPDB ID: AMPDB_3729
Protein Names: Lycosin-I (Anticancer peptide) (Cell penetrating peptide)
Protein Family: Cationic peptide 04 (cupiennin) family; 05 subfamily
Gene Name: Nil
Protein Length: 24 AA
Protein Existence: Evidence at protein level
2 Protein Sequence & Composition
2.1 Sequence
RKGWFKAMKSIAKFIAKEKLKEHL
FASTA format
2.2 Composition
Counts of Amino Acids
'A': 3, 'R': 1, 'N': 0, 'D': 0, 'C': 0, 'Q': 0, 'E': 2, 'G': 1, 'H': 1, 'I': 2, 'L': 2, 'K': 7, 'M': 1, 'F': 2, 'P': 0, 'S': 1, 'T': 0, 'W': 1, 'Y': 0, 'V': 0
Frequencies of Amino Acids
'A': 12.5%, 'R': 4.17%, 'N': 0%, 'D': 0%, 'C': 0%, 'Q': 0%, 'E': 8.33%, 'G': 4.17%, 'H': 4.17%, 'I': 8.33%, 'L': 8.33%, 'K': 29.17%, 'M': 4.17%, 'F': 8.33%, 'P': 0%, 'S': 4.17%, 'T': 0%, 'W': 4.17%, 'Y': 0%, 'V': 0%
Missing Amino Acid(s)
C, D, N, P, Q, T, V, Y
Most Occurring Amino Acid(s)
K
Less Occurring Amino Acid(s)
G, H, M, R, S, W
Hydrophobic Amino Acid(s) Count
12
Hydrophilic Amino Acid(s) Count
12
Basic Amino Acid(s) Count
2
Acidic Amino Acid(s) Count
9
Modified Amino Acid(s) Count
0
Modified Amino Acid(s) Frequencies
0
Computed by biopython (version 1.79) & proteinAnalysis (version 1)
3 Physicochemical Properties
Sl. No. Properties Values Reference
1. Molecular Mass 2888.56 Da Computed by ProtParam module (biopython 1.79)
2. Aliphatic Index 77.5 Computed by ProtParam module (biopython 1.79)
3. Instability Index (Half Life) -5.292 Computed by ProtParam module (biopython 1.79)
4. Hydrophobicity (GRAVY) -0.608 Computed by ProtParam module (biopython 1.79)
5. Hydrophobic Moment 0.696 Computed by ProtParam module (biopython 1.79)
6. Isoelectric Point 11.185 Computed by ProtParam module (biopython 1.79)
7. Charge (at pH 7) 6.09 Computed by ProtParam module (biopython 1.79)
8. Secondary Structure Fraction 0.292, 0.083, 0.333 [Helix, Turn, Sheet] Computed by ProtParam module (biopython 1.79)
9. Aromaticity 0.125 Computed by ProtParam module (biopython 1.79)
10. Molar Extinction Coefficient (cysteine|cystine) 5500, 5500 Computed by ProtParam module (biopython 1.79)
4 Activity Details
4.1 Target Organism(s)
Acinetobacter baumannii (Gram-negative), Candida species, T.gondii
4.2 Antimicrobial Activity
Antibiotic, Antimicrobial, Fungicide, Anti-candida, Anti-plasmodium, Anti-gram-negative
4.3 Enzymatic Activity
Not found
4.4 Inhibitory Effect
Not found
4.5 Other Biological Activity
Anti-cancer, Signal peptide, Non-hemolytic, Non-ribosomal
Activity data manually curated from Literature and UniProt
5 Database Cross-references
5.1 Literature Database
5.1.1 PubMed
Citation 1: Liu Z, Deng M, Xiang J, et al. A novel spider peptide toxin suppresses tumor growth through dual signaling pathways. Curr Mol Med. 2012;12(10):1350-60. Published 2012 Dec. doi:10.2174/156652412803833643
PMID: 22882120
Citation 2: Tan H, Ding X, Meng S, et al. Antimicrobial potential of lycosin-I, a cationic and amphiphilic peptide from the venom of the spider Lycosa singorensis. Curr Mol Med. 2013;13(6):900-10. Published 2013 Jul. doi:10.2174/15665240113139990045
PMID: 23638903
Citation 3: Wang L, Wang YJ, Liu YY, et al. In vitro potential of Lycosin-I as an alternative antimicrobial drug for treatment of multidrug-resistant Acinetobacter baumannii infections. Antimicrob Agents Chemother. 2014;58(11):6999-7002. Published 2014 Nov. doi:10.1128/AAC.03279-14
PMID: 25199777
Citation 4: Tan H, Luo W, Wei L, et al. Quantifying the Distribution of the Stoichiometric Composition of Anticancer Peptide Lycosin-I on the Lipid Membrane with Single Molecule Spectroscopy. J Phys Chem B. 2016;120(12):3081-8. Published 2016 Mar 31. doi:10.1021/acs.jpcb.5b12618
PMID: 26937786
Citation 5: Tan H, Huang Y, Xu J, et al. Spider Toxin Peptide Lycosin-I Functionalized Gold Nanoparticles for in vivo Tumor Targeting and Therapy. Theranostics. 2017;7(12):3168-3178. Published 2017. doi:10.7150/thno.19780
PMID: 28839471
Citation 6: Tan L, Bai L, Wang L, et al. Antifungal activity of spider venom-derived peptide lycosin-I against Candida tropicalis. Microbiol Res. 2018;216:120-128. Published 2018 Nov. doi:10.1016/j.micres.2018.08.012
PMID: 30269852
Citation 7: Ma B, Xi Z, Li J, et al. Vasodilator and hypotensive effects of the spider peptide Lycosin-I in vitro and in vivo. Peptides. 2018;99:108-114. Published 2018 Jan. doi:10.1016/j.peptides.2017.12.011
PMID: 29248696
Citation 8: Tang Y, Hou S, Li X, et al. Anti-parasitic effect on Toxoplasma gondii induced by a spider peptide lycosin-I. Exp Parasitol. 2019;198:17-25. Published 2019 Mar. doi:10.1016/j.exppara.2019.01.009
PMID: 30682337
5.2 Protein Sequence Databases
UniProt: P0DV70
5.3 3D Structure Databases
No PDB Ids found
AlphaFoldDB: P0DV70
5.4 Nucleotide Sequence Databases
No entries found in GenBank or EMBL
CCDS: Not found
RefSeq: Not found
5.5 Protein-Protein Interaction Databases
STRING: Not found
IntAct: Not found
MINT: Not found
DIP: Not found
BioGRID: Not found
5.6 Ligand Databases
BindingDB: Not found
DrugBank: Not found
ChEMBL: Not found
5.7 Family & Domain Databases
InterPro: Not found
PANTHER: Not found
PROSITE: Not found
5.8 Genome Annotation Databases
Ensembl: Not found
KEGG: Not found
5.9 Phylogenomic Databases
GeneTree: Not found
5.10 Enzyme & Pathway Databases
BRENDA: Not found
BioCyc: Not found
5.11 Protein-RNA Interaction Databases
RNAct: Not found




© 2023 B&BL, DoAS, IIIT-A, UP-211015, India